• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,515.49 596.73
( 0.81%)
Global Indices
Nasdaq
50,884.98 77.97
(0.15%)
Dow Jones
7,407.31 -19.42
(-0.26%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,242.24 -130.96
(-1.26%)
Forex
USD-INR
95.53 0.30
(0.32%)
EUR-INR
110.14 0.47
(0.43%)
GBP-INR
127.43 0.45
(0.36%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

genpharmasec limited
Eiko Lifesciences consolidated net profit rises 23.81% in the March 2026 quarter
May 26,2026
Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales18.3411.27 63 52.7137.66 40
OPM %12.3211.62 -14.107.33 -
PBDT2.271.55 46 8.133.46 135
PBT2.021.30 55 7.122.72 162
NP1.301.05 24 4.502.11 113